News ReleasesPrinter friendly version
Protox Therapeutics to be featured on CEO Clips on The Biography Channel
Monday, March 27, 2006 - Vancouver, British Columbia - CEO Clips, a series of two minute corporate profiles on Canadian companies, will feature Protox Therapeutics Inc. (TSX-V: PRX) on The Biography Channel beginning March 27, 2006 at various times throughout the day and evening. It will also be posted on Yahoo Finance Canada and can be viewed online at www.protoxtherapeutics.com.
About The Biography Channel:
Over half of Canadians in digital households watch The Biography Channel,
according to the Roper Report 2005. The Biography Channel finished #1 in awareness,
viewer ship and importance to the enjoyment of cable in the latest Beta Research
Subscriber study of digital cable subscribers and can currently be viewed in 800,000
Canadian homes.
About Protox Therapeutics:
Protox Therapeutics is a product-focused development-stage company and a leader in
advancing novel, targeted protein toxin therapeutics for treatment of cancer and other
diseases. Through the company's PORxin™ technology platform, therapeutic candidates are
generated by engineering the naturally occurring protein, pro-aerolysin. These proteins
become potent anti-cancer agents when activated at a tumor site by specific proteases
produced by cancer cells. Once activated, the drug punches holes in the cancer cells
causing the contents to leak out and ultimately, cell death. Protox has received clearance
from the FDA to commence Phase 1 clinical trials with the lead compound, PRX302, for the
treatment of localized prostate cancer. PRX302 is also being developed for treatment of
benign prostatic hyperplasia.
Link to the webcast replay of the CEO Clips spot on the Biography Channel.
For more information, contact:
Elayne Wandler
Director, Investor Relations and Corporate Communications, Protox Therapeutics Inc.
Direct: 604-688-4369
Cell: 778-865-0172
Fax: 604-688-0173
ewandler@protoxtherapeutics.com
| 
